Given Imaging Announces PillCam(TM) Capsule Endoscopy Studies to Be Presented at Digestive Disease Week 200621 May 2006
Digestive Disease Week® 2006 Booth 644 --Given Imaging (NASDAQ: GIVN) announced today that 86 abstracts on PillCamcapsule endoscopy will be presented at this year's Digestive DiseaseWeek® 2006 (DDW®) medical meeting from May 20 to 25 in Los Angeles.Given Imaging will host several educational "Meet the Experts" sessionsthroughout the week at booth number 644. Among the clinical data to be presented on PillCam capsule endoscopy are: Iron Deficiency Anemia -- "Comparison of Wireless Video Small Bowel Capsule Endoscopy (CE) and Upper Endoscopy (EGD) in Evaluation of Iron-deficiency Anemia (IDA) in Patients with Negative Colonoscopy," (Abstract M1301) Monday, May 22, 2006, 8:00 a.m. West Hall A (Los Angeles Convention Center Clinical Practice/Outcomes -- "Capsule Endoscopy Findings and Clinical Outcomes in Patients with Obscure Gastrointestinal Bleeding," (Abstract S1463) Sunday, May 21, 2006, 8:00 a.m. West Hall A (Los Angeles Convention Center)-- "Capsule Endoscopy: Benefit in Evaluation of 'Missed' Endoscopic Lesions in Obscure GI bleeding," (Abstract M1247) Monday, May 22, 2006, 8:00 a.m. West Hall A (Los Angeles Convention Center)-- "Impact of Capsule Endoscopy on Clinical Outcomes," (Abstract M1323); Monday, May 22, 2006, 8:00 a.m. West Hall A (Los Angeles Convention Center)-- "Capsule Endoscopy for Obscure Gastrointestinal Bleeding: A Report of 100 Consecutive Cases to Investigate Long Term Clinical Outcomes," (Abstract M1259); Monday, May 22, 2006, 8:00 a.m. West Hall A (Los Angeles Convention Center)-- "Long Term Follow-up of Patients with Obscure Gastrointestinal Bleeding after Negative Endoscopy," (Presentation # 500) Tuesday, May 23, 2006, 9:30 a.m. 511 A/B/C (Los Angeles Convention Center Crohn's Disease -- "Mucosal Healing in the Small Intestine Detected by Wireless Capsule Endoscopy," (Abstract S1407) Sunday, May 21, 2006, 8:00 a.m. West Hall A; (Los Angeles Convention Center)-- "Usefulness of the Capsule Endoscopy in the Study of Inflammatory Bowel Disease: Preliminary results," (Abstract T1122) Tuesday, May 23, 2006, 8:30 a.m. West Hall A (Los Angeles Convention Center) Given Imaging will also host teleconference on Friday, May 26th at 10:30 amET to summarize the key abstracts presented at this year's DDW. Toparticipate in the teleconference, please dial 800-289-0572 fifteen minutesbefore the conference begins. International callers should dial913-981-5543. The call will also be webcast live at www.givenimaging.com.A replay of the call will be available on the company's website by dialing888-203-1112. International callers should dial 719-457-0820. The replayparticipant code is 8747793. About Digestive Disease Week Digestive Disease Week (DDW) is the largest international gathering ofphysicians, researchers and academics in the fields of gastroenterology,hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored bythe American Association for the Study of Liver Diseases (AASLD), theAmerican Gastroenterological Association (AGA), the American Society forGastrointestinal Endoscopy (ASGE) and the Society for Surgery of theAlimentary Tract (SSAT), DDW takes place May 20-25, 2006 in Los Angeles, atthe Los Angeles Convention Center. The meeting showcases approximately5,000 abstracts and hundreds of lectures on the latest advances in GIresearch, medicine and technology. For more information, visitwww.ddw.org. About Given Imaging Given Imaging is redefining gastrointestinal diagnosis by developing,producing and marketing innovative, patient-friendly products for detectinggastrointestinal disorders. The company is developing a complete line ofPillCam™ video capsules for detecting disorders of the gastrointestinaltract. The company's technology platform is the Given® System, featuringthe PillCam video capsule, a disposable, miniature video camera containedin a capsule, which is ingested by the patient. The PillCam SB capsule is anaturally ingested method for direct visualization of the entire smallintestine. It is currently marketed in the United States and in more than50 other countries and has benefited more than 340,000 patients worldwide.The PillCam ESO video capsule, which provides visual examination of theesophagus, has been cleared for marketing by the FDA. Additional capsulesfor visualization of the stomach and colon are under development. GivenImaging's headquarters, manufacturing, and R&D facilities are located inYoqneam, Israel; it has direct sales and marketing operations in the UnitedStates, Germany and France, and local offices in Japan, Spain, andAustralia. For more information, visit http://www.givenimaging.com. This press release contains forward-looking statements about Given Imaging,including projections about our business and our future revenues, expensesand profitability, within the meaning of Section 27A of the Securities Actof 1933 and Section 21E of the Securities Exchange Act of 1934. Forexample, statements in the future tense, words such as "anticipates,""estimates," "expects," "intends," "plans," "believes," and words and termsof similar substance used in connection with any discussion of futureoperating or financial performance identify such forward-lookingstatements. Those forward-looking statements are not guarantees of futureperformance and actual results could differ materially from our currentexpectations as a result of numerous factors, including but not limited tothe following: changes in regulatory environment, our success inimplementing our sales, marketing and manufacturing plan, protection andvalidity of patents and other intellectual property rights, the impact ofcurrency exchange rates, the effect of competition by other companies, theoutcome of future litigation, the reimbursement policies for our productfrom healthcare payors, quarterly variations in operating results, theimpact of the newly adopted SFAS 123R for expensing option-based payments,the possibility of armed conflict or civil or military unrest in Israel andother risks disclosed in our filings with the U.S. Securities and ExchangeCommission. For further information contact:Fern LazarDavid CareyLazar Partners Ltd.Phone: 1-866-GIVEN-IREmail ContactEmail Contact SOURCE: Given Imaging
Source: marketwire
All trademarks and copyrighted information contained herein are the property of their respective owners.
Related Articles
|